Paralytic rabies accounts for approximately 20–33% of human rabies cases and is characterized by ascending lower motor neuron weakness beginning at the site of exposure, with preserved consciousness until the preterminal phase — distinguishing it from the more common encephalitic ("furious") form. [1-2] It is nearly universally fatal once clinical signs appear, with average survival of 11 days from symptom onset without intensive care (vs. 5.7 days for furious rabies). [1]
1. History
- Exposure history: Bite, scratch, or mucous membrane contact with a mammal — especially dogs (globally), bats (US/Americas), foxes, raccoons, skunks, coyotes [3-4]
- Incubation period: typically weeks to months (range: 7 days to years); bites to highly innervated areas (face, hands) may shorten incubation [3]
- Prodrome: Pain, paresthesia, or pruritus at the bite site is often the earliest symptom, followed by fever, malaise, headache [3][5]
- Progression: Weakness begins in the bitten extremity, then ascends as flaccid paralysis; consciousness is preserved early [1]
- Ask about: animal behavior (unprovoked attack, nocturnal animal active during day), vaccination status of animal, PEP history, travel to endemic regions [3-4]
- Critical pitfall: Exposure history may be absent or forgotten — up to 30% of cases lack a clear bite history; bat bites may leave no visible marks [6-7]
2. Alarm Features
- Rapidly ascending paralysis with fever and paresthesias at a wound site
- Bladder incontinence (distinguishes from GBS) [1]
- Fasciculations, myoedema (percussion-induced muscle mounding — highly suggestive of rabies) [1]
- Any progression to altered sensorium, autonomic instability, or respiratory failure
- Dysphagia or inspiratory spasms developing in a patient with ascending weakness
- Hydrophobia/aerophobia (may appear late or not at all in paralytic form) [1][5]
3. Medications
- No effective antiviral therapy exists once clinical rabies develops [2][8]
- The Milwaukee Protocol (therapeutic coma with ketamine, midazolam, ribavirin, amantadine) has been attempted but is largely unsuccessful for dog-variant RABV [1-2]
- Post-exposure prophylaxis (PEP) is the only effective intervention and must be given before symptom onset:
- Unvaccinated: HRIG 20 IU/kg (infiltrated into/around wound) + rabies vaccine 1 mL IM on days 0, 3, 7, 14 (4-dose ACIP schedule) [4][9]
- Previously vaccinated: 2 doses vaccine on days 0 and 3; no RIG [4]
- IVIG given empirically for suspected GBS can confound rabies serology (passive rabies antibodies from donor serum) [3]
- Avoid corticosteroids if rabies is in the differential — immunosuppression may accelerate disease
4. Diet
- Not a primary management consideration
- Dysphagia is common as disease progresses — aspiration precautions and early consideration of enteral feeding via NG/OG tube
- Hydration support is critical given autonomic dysfunction and inability to swallow
5. Review of Systems
- Neurologic: Weakness pattern (ascending vs. descending), paresthesias, pain at bite site, fasciculations, bladder/bowel dysfunction, altered mental status
- Autonomic: Hypersalivation, diaphoresis, piloerection, cardiac arrhythmias, priapism
- Respiratory: Dyspnea, inspiratory spasms, inability to clear secretions
- Psychiatric: Agitation, anxiety, hallucinations (more common in furious form but can overlap)
- Constitutional: Fever, malaise, anorexia
6. Collateral History and Family History
- Collateral is critical: Witnesses to animal exposure, family members who may recall a bite/scratch the patient has forgotten
- Travel history to rabies-endemic regions (Asia, Africa, Latin America) [8]
- Occupational exposure: veterinarians, animal handlers, laboratory workers, spelunkers (bat caves) [10]
- Prior PEP or pre-exposure vaccination history — PEP failures, though rare, have been documented with deviations from protocol [11]
- Family history is not directly relevant (rabies is not hereditary)
7. Risk Factors
- Dog bites in endemic countries (99% of global human rabies) [8]
- Bat exposure in the US — most common domestic source; bites may be imperceptible [7]
- Bites to face, hands, or highly innervated areas — higher risk of infection and shorter incubation [3]
- Deep, multiple, or unprovoked bites [4]
- Failure to receive or complete PEP after exposure [11]
- Children (more likely to have unreported animal contact) [7]
- Travelers to rural areas in Asia/Africa without pre-exposure vaccination [8]
- Organ/tissue transplant from undiagnosed rabies donors (rare) [4]
8. Differential Diagnosis
The paralytic form is a notorious diagnostic mimic of Guillain-Barré syndrome (GBS): [1][6][12-14]
- Guillain-Barré syndrome (most common misdiagnosis): Key distinguishing features of paralytic rabies include fever, preserved consciousness early, bladder incontinence, fasciculations, myoedema, CSF pleocytosis (vs. albuminocytologic dissociation in GBS), and progression to coma [1][6]
- Transverse myelitis / acute myelitis
- Poliomyelitis / enteroviral anterior myelitis (West Nile virus)
- Acute disseminated encephalomyelitis (ADEM)
- Botulism (descending paralysis — opposite pattern)
- Diphtheric neuropathy
- Tick paralysis
- Toxic neuropathies (heavy metals, organophosphates) [13]
- Spinal cord compression
9. Past Medical History
- Prior animal bites or scratches (even remote — incubation can be years) [6]
- Previous rabies vaccination or PEP (and completeness of series)
- Immunocompromised states (HIV, transplant, chemotherapy) — may alter PEP response; ACIP recommends 5-dose series + RIG for immunocompromised patients [9]
- History of organ/tissue transplantation
10. Physical Exam
- Vital signs: Fever, tachycardia, blood pressure lability (autonomic dysfunction) [3]
- Neurologic:
- Flaccid weakness beginning at the bitten limb, ascending [1][5]
- Areflexia in affected limbs
- Fasciculations — present in paralytic rabies, uncommon in GBS [6]
- Myoedema (percussion-induced muscle mounding) — highly characteristic [1]
- Sensory exam: typically motor-predominant with only mild sensory involvement [1]
- Bladder distension (incontinence/retention)
- Cranial nerves: Facial weakness, dysphagia may develop
- Inspection of bite site: Look for healed wound, scar, or local inflammation
- Hydrophobia/aerophobia testing (offer water, fan air toward face) — may be absent in paralytic form [5]
11. Lab Studies
- CSF analysis: Pleocytosis (lymphocytic) with mildly elevated protein — distinguishes from classic GBS (which shows albuminocytologic dissociation). However, some paralytic rabies cases can show elevated protein with minimal cells, mimicking GBS [6][12]
- Rabies-specific diagnostics (coordinate with state health department/CDC): [3][15]
- RT-PCR (NAAT) on saliva (sensitivity ~70% on single sample; >98% on serial samples), nuchal skin biopsy, CSF [1][5]
- Nuchal skin biopsy (nape of neck, containing hair follicles): Direct fluorescent antibody (DFA) for rabies antigen in cutaneous nerves — nearly 100% sensitive [1]
- Serum and CSF antibodies (RFFIT): CSF antibody in an unvaccinated patient confirms diagnosis; serum antibody alone is less specific [3][16]
- Routine labs: CBC, CMP, LFTs — generally nonspecific
- Important caveat: Negative results on a single sample do not exclude rabies; sequential sampling is essential. Sensitivity of RT-PCR is lower in paralytic rabies than furious rabies (negative saliva in 78% vs. 15%) [1][3]
12. Imaging
- Brain MRI: Subtle, nonspecific changes; typically shows absence of gadolinium enhancement (unlike most other encephalitides). Mild T2/FLAIR signal changes may be seen in brainstem, hippocampus, or spinal cord [1]
- Spinal MRI: May show enhancement of nerve roots or cauda equina, mimicking GBS [12]
- Imaging is primarily useful to exclude other diagnoses (cord compression, transverse myelitis, ADEM)
- CT head: Usually normal; low yield
13. Special Tests
- Nuchal skin biopsy (full-thickness, 5–6 mm punch from nape of neck containing hair follicles): DFA for rabies antigen in peripheral nerve fibers [15]
- Corneal impression smear: DFA for rabies antigen — limited sensitivity [6]
- Electromyography/Nerve conduction studies (EMG/NCS): May show axonal motor neuropathy or demyelinating pattern, overlapping with GBS variants [1][13-14]
- Rapid fluorescent focus inhibition test (RFFIT): Gold standard for neutralizing antibody detection in serum/CSF [16]
- Post-mortem: Brain DFA and Negri bodies (eosinophilic cytoplasmic inclusions in hippocampal and Purkinje neurons) — pathognomonic [17]
14. ECG
- Autonomic dysfunction can produce cardiac arrhythmias: sinus tachycardia, bradycardia, ST changes, heart block [3][12]
- ECG should be obtained in all suspected cases
- Cardiac complications (including myocarditis-like presentations) have led to misdiagnosis — at least one traveler underwent cardiac catheterization before rabies was suspected [3]
- Monitor for arrhythmias continuously in ICU setting
15. Assessment
- Paralytic rabies is a uniformly fatal acute viral encephalomyelitis presenting as ascending flaccid paralysis with preserved consciousness early in the course [1-2]
- It is frequently misdiagnosed as GBS at initial presentation, especially when bite history is absent [6][12-13][18]
- Clinical clues favoring rabies over GBS: fever, bite-site paresthesias, fasciculations, myoedema, bladder incontinence, CSF pleocytosis, rapid progression to coma [1][6]
- Average survival from symptom onset is ~11 days without ICU support; can be extended to ~1 month with aggressive care, but outcome remains fatal [1]
- Rabies diagnosis in the US is almost always missed at the first clinical encounter [3]
16. Treatment Plan
Pre-symptomatic (post-exposure, pre-clinical)
- Wound care: Thorough irrigation with soap and water or povidone-iodine for ≥15 minutes; do not suture unless absolutely necessary [4-5]
- HRIG: 20 IU/kg infiltrated into and around wound on day 0 (can be given up to day 7 after first vaccine dose); remainder IM at distant site [4][9]
- Rabies vaccine: 1 mL IM (deltoid in adults, anterolateral thigh in children) on days 0, 3, 7, 14 [9]
- Tetanus prophylaxis and antibiotics as indicated
Symptomatic (clinical rabies established)
- ICU admission with aggressive supportive care
- Airway management: Early intubation for respiratory failure
- Hemodynamic monitoring and vasopressor support for autonomic instability
- Seizure management with benzodiazepines
- No proven effective antiviral therapy exists [2]
- Palliative care discussion should be initiated early given near-universal fatality
- Strict infection control: Standard precautions; rabies is not transmitted by casual contact, but avoid exposure to saliva and neural tissue [4]
17. Disposition
- All suspected clinical rabies cases require ICU admission [1-2]
- Immediate notification of state/local public health department and CDC (nationally notifiable disease) [3][15]
- Infectious disease and neurology consultation
- If rabies is in the differential for a patient with ascending paralysis, do not discharge — pursue rabies-specific diagnostics urgently
- Post-exposure patients (pre-symptomatic) can be managed outpatient with scheduled PEP vaccine doses and close follow-up
18. Follow Up / Return Precautions
For post-exposure (PEP) patients
- Ensure completion of the full vaccine series (days 0, 3, 7, 14) [9]
- Return immediately for: fever, paresthesias or pain at bite site, weakness, behavioral changes, difficulty swallowing, hydrophobia
- Immunocompromised patients should have antibody titers checked 2 weeks after completing the series [9]
For clinical rabies
- Prognosis is nearly universally fatal once symptoms develop [2]
- Family counseling regarding prognosis and goals of care
- Identify and provide PEP to all contacts with potential exposure to patient's saliva or neural tissue [7]
- Expected course: progressive paralysis → coma → cardiorespiratory failure → death, typically within 2–4 weeks [1]
References
1. Human Rabies: Neuropathogenesis, Diagnosis, and Management. — Hemachudha T, Ugolini G, Wacharapluesadee S, et al. The Lancet. Neurology. 2013.
2. Rabies: A Medical Perspective. — Jackson AC. Revue Scientifique Et Technique. 2018.
3. Rabies. — Ryan M. Wallace and David R. Shlim CDC Yellow Book. 2025.
4. FDA Drug Label. — Food and Drug Administration (DailyMed)..
5. Current Status of Rabies and Prospects for Elimination. — Fooks AR, Banyard AC, Horton DL, et al. Lancet. 2014.
6. Rabies Viral Encephalitis: Clinical Determinants in Diagnosis With Special Reference to Paralytic Form. — Gadre G, Satishchandra P, Mahadevan A, et al. Journal of Neurology, Neurosurgery, and Psychiatry. 2010.
7. Human Rabies - Texas, 2021. — Blackburn D, Minhaj FS, Al Hammoud R, et al. MMWR. Morbidity and Mortality Weekly Report. 2022.
8. Boostability After Single-Visit Pre-Exposure Prophylaxis With Rabies Vaccine: A Randomised Controlled Non-Inferiority Trial. — Overduin LA, Koopman JPR, Prins C, et al. The Lancet. Infectious Diseases. 2024.
9. Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices. — Rupprecht CE, Briggs D, Brown CM, et al. MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports. 2010.
10. Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. — Rao AK, Briggs D, Moore SM, et al. MMWR. Morbidity and Mortality Weekly Report. 2022.
11. Human Rabies Despite Post-Exposure Prophylaxis: A Systematic Review of Fatal Breakthrough Infections After Zoonotic Exposures. — Whitehouse ER, Mandra A, Bonwitt J, et al. The Lancet. Infectious Diseases. 2023.
12. From Initial Suspicion to Accurate Diagnosis: Unmasking Rabies in a Case of Suspected Guillain-Barre Syndrome. — Khadra MN, Abdat W, Alawneh M, et al. BMC Pediatrics. 2025.
13. Paralytic Rabies Outbreak Mimicking Guillain-Barré Syndrome in French Amazonia. — Deschamps N, Mayence C, Parize P, et al. PLoS Neglected Tropical Diseases. 2026.
14. Overlap of Pathology in Paralytic Rabies and Axonal Guillain-Barre Syndrome. — Sheikh KA, Ramos-Alvarez M, Jackson AC, et al. Annals of Neurology. 2005.
15. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.
16. Utility of Rabies Neutralizing Antibody Detection in Cerebrospinal Fluid and Serum for Ante-Mortem Diagnosis of Human Rabies. — Damodar T, Mani RS, Prathyusha PV. PLoS Neglected Tropical Diseases. 2019.
17. Histopathology of vaccine‐preventable diseases. — Solomon IH, Milner DA. Histopathology. 2017.
18. Human Rabies: A Disease of Complex Neuropathogenetic Mechanisms and Diagnostic Challenges. — Hemachudha T, Laothamatas J, Rupprecht CE. The Lancet. Neurology. 2002.